Biomarin
BioMarin develops and commercialises innovative biopharmaceuticals for rare diseases driven by genetic causes.
Financial Data
-
31st Dec 19 Source: CRO
- €1 billion turnover
-
€42 million
profit - 434 employees
-
31st Dec 18 Source: CRO
- €1.1 billion turnover
-
€43 million
profit - 385 employees
- 4 more years available »
Ranking
By Turnover
(€1 billion)- 94th in Top Companies
- 16th in Health
By Employees
(434)- 410th in Top Companies
- 62nd in Health
- 434
- €1 billion
Employees
- Michael O’Donnell CEO/Managing Director
Latest News
- Oct 20 European stocks reach six-week highs as Nestle shines
- Oct 20 European stocks reach six-week highs as Nestlé shines
- Oct 20 Rugby deal values values Pro-14 tournament business at €333.8m
- Oct 20 Tenants in Dublin affordable housing scheme could be charged for parking spaces
- Oct 20 Affordable housing scheme tenants could be charged for parking spaces